First human tests begin for promising new eczema injection
Disease control
Recruiting now
This early-stage study is testing a new injectable medication called BxC-I17e for adults with moderate-to-severe atopic dermatitis (eczema). Researchers will give 45 participants either the drug or a placebo to check for side effects and see if it helps reduce skin symptoms. The …
Phase: PHASE1 • Sponsor: Brexogen Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC